A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer



Status:Completed
Conditions:Ovarian Cancer, Neurology
Therapuetic Areas:Neurology, Oncology
Healthy:No
Age Range:18 - Any
Updated:12/14/2016
Start Date:June 2013
End Date:June 2016

Use our guide to learn which trials are right for you!

A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study of
niraparib as maintenance in platinum sensitive ovarian cancer patients who have either
gBRCAmut or a tumor with high-grade serous histology and who have responded to their most
recent chemotherapy containing a platinum agent. Niraparib is an orally active PARP
inhibitor. Niraparib or placebo (in a 2:1 ratio) will be administered once daily
continuously during a 28-day cycle. Health-related quality of life will be measured by the
Functional Assessment of Cancer Therapy - Ovarian Symptom Index (FOSI), European Quality of
Life scale, 5-Dimensions (EQ-5D), and a neuropathy questionnaire. Safety and tolerability
will be assessed by clinical review of adverse events (AEs), physical examinations,
electrocardiograms (ECGs), and safety laboratory values.

The primary objective of this study is to evaluate efficacy of niraparib as maintenance
therapy in patients who have platinum sensitive ovarian cancer as assessed by the
prolongation of progression free survival (PFS).


Inclusion Criteria:

- 18 years of age or older, female, any race

- Histologically diagnosed ovarian cancer, fallopian tube cancer or primary peritoneal
cancer

- High grade (or grade 3) serous histology or known to have gBRCAmut

- Has received at least 2 previous courses of platinum-containing therapy, and has
disease that was considered platinum sensitive following the penultimate (next to
last) platinum course (more than 6 month period between penultimate platinum regimen
and progression of disease)

- Has responded to last the platinum regimen, remains in response and is enrolled on
study within 8 weeks of completion of the last platinum regimen

- ECOG 0-1

- Adequate bone marrow, kidney and liver function

Exclusion Criteria:

- Known hypersensitivity to the components of niraparib

- Invasive cancer other than ovarian cancer within 2 years (except basal or squamous
cell carcinoma of the skin that has been definitely treated)

- Symptomatic uncontrolled brain metastasis

- Is pregnant or breast feeding

- Immunocompromised patients

- Known active hepatic disease

- Prior treatment with a known PARP inhibitor
We found this trial at
36
sites
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Abington, PA
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Austin, TX
Click here to add this to my saved trials
?
mi
from
Boston, MA
Click here to add this to my saved trials
?
mi
from
Burlington, MA
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
?
mi
from
Durham, NC
Click here to add this to my saved trials
?
mi
from
Farmington, NM
Click here to add this to my saved trials
?
mi
from
Fort Worth, TX
Click here to add this to my saved trials
?
mi
from
Graz,
Click here to add this to my saved trials
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
?
mi
from
La Jolla, CA
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
?
mi
from
Morristown, NJ
Click here to add this to my saved trials
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
New Haven, CT
Click here to add this to my saved trials
?
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
?
mi
from
Orange, CA
Click here to add this to my saved trials
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
?
mi
from
Providence, RI
Click here to add this to my saved trials
?
mi
from
Rochester, MN
Click here to add this to my saved trials
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
?
mi
from
Sarasota, FL
Click here to add this to my saved trials
?
mi
from
Stanford, CA
Click here to add this to my saved trials
?
mi
from
Tampa, FL
Click here to add this to my saved trials
?
mi
from
The Woodlands, TX
Click here to add this to my saved trials
?
mi
from
Tucson, AZ
Click here to add this to my saved trials
?
mi
from
Vancouver, WA
Click here to add this to my saved trials
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials